Logo image of ACA.PA

CREDIT AGRICOLE SA (ACA.PA) Stock Fundamental Analysis

EPA:ACA - Euronext Paris - Matif - FR0000045072 - Common Stock - Currency: EUR

15.585  +0.08 (+0.48%)

Fundamental Rating

2

Overall ACA gets a fundamental rating of 2 out of 10. We evaluated ACA against 96 industry peers in the Banks industry. Both the profitability and financial health of ACA have multiple concerns. ACA has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally ACA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACA was profitable.
ACA had a negative operating cash flow in the past year.
ACA had positive earnings in each of the past 5 years.
In multiple years ACA reported negative operating cash flow during the last 5 years.
ACA.PA Yearly Net Income VS EBIT VS OCF VS FCFACA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

ACA has a Return On Assets of 0.46%. This is in the lower half of the industry: ACA underperforms 67.71% of its industry peers.
The Return On Equity of ACA (14.18%) is better than 76.04% of its industry peers.
Industry RankSector Rank
ROA 0.46%
ROE 14.18%
ROIC N/A
ROA(3y)0.26%
ROA(5y)0.23%
ROE(3y)8.05%
ROE(5y)7.15%
ROIC(3y)N/A
ROIC(5y)N/A
ACA.PA Yearly ROA, ROE, ROICACA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of ACA (14.28%) is worse than 75.00% of its industry peers.
ACA's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ACA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 14.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.65%
PM growth 5Y16.08%
GM growth 3YN/A
GM growth 5YN/A
ACA.PA Yearly Profit, Operating, Gross MarginsACA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

0

2. Health

2.1 Basic Checks

ACA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACA has about the same amount of shares outstanding.
ACA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACA has a worse debt to assets ratio.
ACA.PA Yearly Shares OutstandingACA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
ACA.PA Yearly Total Debt VS Total AssetsACA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T 2T

2.2 Solvency

A Debt/Equity ratio of 4.26 is on the high side and indicates that ACA has dependencies on debt financing.
ACA's Debt to Equity ratio of 4.26 is on the low side compared to the rest of the industry. ACA is outperformed by 82.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.41%
ACA.PA Yearly LT Debt VS Equity VS FCFACA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ACA.PA Yearly Current Assets VS Current LiabilitesACA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.16% over the past year.
Measured over the past years, ACA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.99% on average per year.
ACA shows a small growth in Revenue. In the last year, the Revenue has grown by 8.00%.
Measured over the past years, ACA shows a decrease in Revenue. The Revenue has been decreasing by -6.66% on average per year.
EPS 1Y (TTM)15.16%
EPS 3Y8.15%
EPS 5Y8.99%
EPS Q2Q%9.8%
Revenue 1Y (TTM)8%
Revenue growth 3Y-10.74%
Revenue growth 5Y-6.66%
Sales Q2Q%6.75%

3.2 Future

ACA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.47% yearly.
The Revenue is expected to grow by 1.52% on average over the next years.
EPS Next Y-0.51%
EPS Next 2Y2.19%
EPS Next 3Y3.08%
EPS Next 5Y-4.47%
Revenue Next Year3.54%
Revenue Next 2Y2.99%
Revenue Next 3Y2.97%
Revenue Next 5Y1.52%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACA.PA Yearly Revenue VS EstimatesACA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
ACA.PA Yearly EPS VS EstimatesACA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.12 indicates a rather cheap valuation of ACA.
ACA's Price/Earnings ratio is rather cheap when compared to the industry. ACA is cheaper than 81.25% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.35. ACA is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 6.98, the valuation of ACA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a rather cheap valuation: ACA is cheaper than 90.63% of the companies listed in the same industry.
ACA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 7.12
Fwd PE 6.98
ACA.PA Price Earnings VS Forward Price EarningsACA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACA.PA Per share dataACA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.79
EPS Next 2Y2.19%
EPS Next 3Y3.08%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.88%, ACA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.14, ACA pays a better dividend. On top of this ACA pays more dividend than 84.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, ACA pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.88%

5.2 History

The dividend of ACA is nicely growing with an annual growth rate of 73.80%!
Dividend Growth(5Y)73.8%
Div Incr Years1
Div Non Decr Years4
ACA.PA Yearly Dividends per shareACA.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DP0%
EPS Next 2Y2.19%
EPS Next 3Y3.08%
ACA.PA Yearly Income VS Free CF VS DividendACA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

CREDIT AGRICOLE SA

EPA:ACA (6/20/2025, 7:00:00 PM)

15.585

+0.08 (+0.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners7.98%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap47.16B
Analysts70
Price Target17.91 (14.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.88%
Yearly Dividend1.05
Dividend Growth(5Y)73.8%
DP0%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.82%
Min EPS beat(2)2.46%
Max EPS beat(2)21.19%
EPS beat(4)4
Avg EPS beat(4)9.8%
Min EPS beat(4)2.46%
Max EPS beat(4)21.19%
EPS beat(8)7
Avg EPS beat(8)17.08%
EPS beat(12)10
Avg EPS beat(12)23.1%
EPS beat(16)14
Avg EPS beat(16)24.55%
Revenue beat(2)1
Avg Revenue beat(2)2.71%
Min Revenue beat(2)-2.67%
Max Revenue beat(2)8.1%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-2.67%
Max Revenue beat(4)8.1%
Revenue beat(8)5
Avg Revenue beat(8)2.23%
Revenue beat(12)8
Avg Revenue beat(12)55.95%
Revenue beat(16)12
Avg Revenue beat(16)121.65%
PT rev (1m)0.2%
PT rev (3m)2.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.52%
EPS NY rev (1m)0%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 7.12
Fwd PE 6.98
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)2.19
EY14.05%
EPS(NY)2.23
Fwd EY14.33%
FCF(TTM)-5.61
FCFYN/A
OCF(TTM)-5.26
OCFYN/A
SpS24.52
BVpS24.69
TBVpS18.19
PEG (NY)N/A
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 0.46%
ROE 14.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.28%
GM N/A
FCFM N/A
ROA(3y)0.26%
ROA(5y)0.23%
ROE(3y)8.05%
ROE(5y)7.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.65%
PM growth 5Y16.08%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.94%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC5.41%
ROIC/WACCN/A
Cap/Depr(3y)85.74%
Cap/Depr(5y)79.48%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.16%
EPS 3Y8.15%
EPS 5Y8.99%
EPS Q2Q%9.8%
EPS Next Y-0.51%
EPS Next 2Y2.19%
EPS Next 3Y3.08%
EPS Next 5Y-4.47%
Revenue 1Y (TTM)8%
Revenue growth 3Y-10.74%
Revenue growth 5Y-6.66%
Sales Q2Q%6.75%
Revenue Next Year3.54%
Revenue Next 2Y2.99%
Revenue Next 3Y2.97%
Revenue Next 5Y1.52%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.43%
OCF growth 3YN/A
OCF growth 5YN/A